PMID: 9165132Apr 1, 1997Paper

Hyperfractionation: where do we stand?

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
H P Beck-BornholdtH Willers

Abstract

Hyperfractionation is generally expected to allow an escalation of total dose, thereby increasing tumour control rate, without increasing the risk of late complications. The purpose of this review is to assess the empirical evidence for this therapeutic gain from hyperfractionated radiotherapy. Although extensive clinical data have been accumulated until now, especially on treatment of head and neck cancer, the line of evidence is not consistent. The present analysis indicates that the dose per fraction generally used in standard radiotherapy is already a good choice.

References

Sep 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G ArcangeliC Nervi
Jan 1, 1976·AJR. American Journal of Roentgenology·L J ShukovskyH R Withers
Mar 1, 1976·International Journal of Radiation Oncology, Biology, Physics·J E MoulderR Milardo
Jul 1, 1976·International Journal of Radiation Oncology, Biology, Physics·J F FowlerS B Field
Jun 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A RojasJ Denekamp
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·D C ShrieveV A Levin
Dec 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H R Withers
Dec 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J C HoriotM Bolla
Feb 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F WürschmidtH P Beck-Bornholdt
Mar 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C S WongR P Hill
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·C VargheseR K Roul
Oct 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M RobinsonG Westbury
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J C Horiot
Oct 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E KjellenA Rojas
Mar 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S M Bentzen, M Overgaard
Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·L H PintoL Souhami
Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·H P Beck-Bornholdt
Mar 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A RojasK Reghebi
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J C HoriotM Bolla
Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·F SanchízL Cirera
Dec 1, 1989·International Journal of Radiation Oncology, Biology, Physics·G B StillwagonE K Fishman
May 1, 1989·Journal of Neurosurgery·M S EdwardsP Silver
Nov 1, 1989·International Journal of Radiation Oncology, Biology, Physics·C D WendtM J Oswald
Aug 1, 1988·International Journal of Radiation Oncology, Biology, Physics·C R FreemanD Norris
Mar 1, 1989·International Journal of Radiation Oncology, Biology, Physics·H P Beck-BornholdtF Würschmidt
Jan 1, 1988·International Journal of Radiation Oncology, Biology, Physics·T D NguyenM Loirette
Feb 1, 1988·International Journal of Radiation Oncology, Biology, Physics·H Vogler, H P Beck-Bornholdt
Mar 1, 1988·International Journal of Radiation Oncology, Biology, Physics·F WürschmidtH P Beck-Bornholdt
Apr 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
Apr 1, 1986·International Journal of Radiation Oncology, Biology, Physics·W van den BogaertE Barthelme
Mar 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H S Reinhold, A G Visser
Apr 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S LaukK R Trott
Nov 1, 1987·International Journal of Radiation Oncology, Biology, Physics·R J PackerD F Nelson
Nov 1, 1987·International Journal of Radiation Oncology, Biology, Physics·M J Weinberg, A M Rauth
Nov 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F EdsmyrB Nilsson
Oct 1, 1985·International Journal of Radiation Oncology, Biology, Physics·H G SeydelM E Francis
Jan 1, 1986·International Journal of Radiation Oncology, Biology, Physics·C C WangP H Blitzer

❮ Previous
Next ❯

Citations

Jun 30, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·S AppoldF Eichhorn
Aug 6, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A RaabeW Alberti
Oct 31, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J L BedfordD M Tait
Sep 5, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ramón GalianaFerran Guedea
Nov 5, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Esther Raaijmakers, Antoine M Engelen
Jan 10, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M AmichettiR Valdagni
Aug 6, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M Stuschke, H D Thames
Feb 5, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S M BentzenS Dische
Sep 29, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·M BaumannT Herrmann
Aug 1, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Thomas HehrWilfried Budach
Jan 25, 2000·Cancer Treatment Reviews·N S Russell, H Bartelink
Feb 25, 1999·Radiation Oncology Investigations·C NiederK Schnabel
Sep 24, 1999·Medical and Pediatric Oncology·M Baumann, H P Beck-Bornholdt
Jan 6, 2005·The Oncologist·Bea PauwelsJan B Vermorken
Nov 12, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·C PetersenJ Helfrich
Nov 27, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·D Riesenbeck, W Dörr

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
M BaumannK K Ang
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
M Stuschke, H D Thames
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
A Raabe, H P Beck-Bornholdt
© 2021 Meta ULC. All rights reserved